Your browser doesn't support javascript.
loading
Similar duration of viral shedding of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant between vaccinated and incompletely vaccinated individuals.
Kandel, Christopher E; Banete, Andra; Taylor, Maureen; Llanes, Andrea; McCready, Janine; Crowl, Gloria; Young, Matthew; Li, Angel X; Chien, Emily; Yim, Winfield; Yip, Lily; Kozak, Robert; McGeer, Allison J; Mubareka, Samira; Powis, Jeff E.
Afiliação
  • Kandel CE; Michael Garron Hospital, Toronto, Ontario, M4C 3E7, Canada.
  • Banete A; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Taylor M; Michael Garron Hospital, Toronto, Ontario, M4C 3E7, Canada.
  • Llanes A; Michael Garron Hospital, Toronto, Ontario, M4C 3E7, Canada.
  • McCready J; Michael Garron Hospital, Toronto, Ontario, M4C 3E7, Canada.
  • Crowl G; Michael Garron Hospital, Toronto, Ontario, M4C 3E7, Canada.
  • Young M; Michael Garron Hospital, Toronto, Ontario, M4C 3E7, Canada.
  • Li AX; Sinai Health System, Toronto, Ontario, Canada.
  • Chien E; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Yim W; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Yip L; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Kozak R; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • McGeer AJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Mubareka S; Sinai Health System, Toronto, Ontario, Canada.
  • Powis JE; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Infect Control Hosp Epidemiol ; 44(6): 1002-1004, 2023 Jun.
Article em En | MEDLINE | ID: mdl-35598890
ABSTRACT
Among outpatients with coronavirus disease 2019 (COVID-19) due to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) δ (delta) variant who did and did not receive 2 vaccine doses at 7 days after symptom onset, there was no difference in viral shedding (cycle threshold difference 0.59, 95% CI, -4.68 to 3.50; P = .77) with SARS-CoV-2 cultured from 2 (7%) of 28 and 1 (4%) of 26 outpatients, respectively.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
...